[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100619534":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":26,"centralContacts":30,"locations":26,"responsibleParty":36,"collaborators":26,"id":40,"slug":41,"hasResults":42,"nctId":43,"briefTitle":44,"officialTitle":45,"acronym":26,"eligibilityCriteria":46,"healthyVolunteers":42,"sex":47,"minAge":48,"maxAge":49,"enrollmentInfo":50,"targetDuration":26,"studyType":53,"phases":54,"briefSummary":56,"conditions":57,"keywords":61,"overallStatus":65,"whyStopped":26,"lastUpdateSubmitDate":66,"lastUpdatePostDateStruct":67,"startDateStruct":70,"completionDateStruct":72,"leadSponsor":74,"locationsCount":26},{"fullName":5,"class":6},"University of Social Welfare and Rehabilitation Science","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Exercise therapy","ACTIVE_COMPARATOR","Participants in this group will receive only the standardized exercise program over two weeks.",[13],"Procedure: Exercise therapy",{"label":15,"type":16,"description":17,"interventionNames":18},"CTDN (Mahshid technique) plus Exercise therapy","EXPERIMENTAL","Participants in this group will receive CTDN targeting the PSIS region together with the standardized exercise program over two weeks.",[19,13],"Procedure: Connective tissue dry needling",[21,27],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"PROCEDURE","Connective tissue dry needling","Connective tissue dry needling: Eight sterile single-use needles placed 1.5 cm from the PSIS center, inserted at about 45° to bony contact, withdrawn 0.5 cm, rotated five times to maximal tissue stiffness, then retained for 20 minutes with concurrent infrared therapy. Three sessions per week for two weeks, total six sessions. Needle size 50 mm × 0.5 mm.",[15],null,{"type":22,"name":9,"description":28,"armGroupLabels":29,"otherNames":26},"Pelvic bridging, leg-lowering, curl-up or bridging, and isolated lumbar stabilizer training. Three sets of ten repetitions for each exercise, three sessions per week for two weeks.",[15,9],[31],{"name":32,"role":33,"phone":34,"phoneExt":26,"email":35},"Mohammad Javaherian, Ph.D.","CONTACT","+989129321391","mohammadjavaherian1372@gmail.com",{"type":37,"investigatorFullName":38,"investigatorTitle":39,"investigatorAffiliation":5,"oldNameTitle":26,"oldOrganization":26},"PRINCIPAL_INVESTIGATOR","Mohammad Javaherian","Principal Investigator","100619534","connective-tissue-dry-needling-for-low-back-pain-related-to-local-posterior-superior-iliac-spine-pain-100619534",false,"NCT07345871","Connective Tissue Dry Needling for Low Back Pain Related to Local Posterior Superior Iliac Spine Pain","Investigating the Effectiveness of Connective Tissue Dry Needling Technique on Patients With Low Back Pain Caused by Local Pain at Superior Posterior Iliac Spine: a Single-blind, Randomized Controlled Trial","Inclusion criteria:\n\n1. Adults aged 18 to 75 years.\n2. Diagnosed with chronic mechanical low back pain localized at the posterior superior iliac spine region.\n3. Presence of point tenderness reproducible by palpation at the posterior superior iliac spine area.\n4. Pain duration of at least two weeks, indicating the non-acute stage of low back pain.\n5. Negative results in at least three out of five sacroiliac pain provocation tests (Distraction, Compression, Thigh Thrust, Sacral Thrust, Gaenslen).\n6. Pain intensity ≥ 3 on the Numeric Rating Scale at baseline.\n7. Ability to communicate and cooperate with the research team during intervention and follow-up.\n8. Access to WhatsApp or equivalent communication application for follow-up pain reporting at the 3-month stage.\n\nNon-inclusion criteria:\n\n1. Presence of lumbar radicular pain or referred pain to the lower limbs.\n2. History of lumbar spine trauma within the previous three months.\n3. Fear or intolerance of needling procedures.\n4. Current use of anticoagulant medication.\n5. Known lymphatic disorders, immunosuppressive diseases, or neurological conditions such as epilepsy or seizure disorders.\n6. Pregnancy or suspected pregnancy.\n\nExclusion criteria:\n\n1. Voluntary withdrawal of consent at any time during the study.\n2. Inability to tolerate the intervention or adverse reaction during treatment sessions.\n3. Occurrence of serious adverse events or complications (e.g., infection, bleeding).\n4. Non-compliance with treatment protocol or missing more than two sessions.\n5. Any intercurrent illness or therapy that could interfere with the study outcomes or safety assessment","ALL","18 Years","75 Years",{"count":51,"type":52},42,"ESTIMATED","INTERVENTIONAL",[55],"NA","This single-blind randomized controlled trial will aim to determine the effectiveness of a connective tissue dry needling (CTDN) technique, in reducing pain and improving function in individuals with chronic mechanical low back pain associated with pain and tenderness at the posterior superior iliac spine (PSIS). Forty participants with local PSIS-related low back pain will be recruited and randomly assigned into two groups using the block balanced randomization method. The treatment group will receive CTDN targeting connective tissue trigger points around the PSIS in addition to a sacroiliac joint stabilization exercise program, while the control group will perform the same exercise program alone under the supervision of a physiotherapist. The intervention protocol will span two weeks, during which participants will attend three treatment sessions per week, for a total of six sessions. The primary outcome measurement will use the Visual Analog Scale (VAS) to assess pain intensity. The study will measure secondary outcomes through lumbar range of motion (ROM) in flexion and extension and pressure pain threshold (PPT), and Roland-Morris Disability Questionnaire (RMDQ) functional disability and Short Form-36 (SF-36) health-related quality of life. The researchers will assess all outcomes at three time points: baseline and after the first session, and the sixth session, while VAS will receive an additional assessment at the 3-month follow-up. The findings of this study are expected to provide evidence supporting CTDN as a safe, effective, and cost-efficient treatment option for PSIS-related mechanical low back pain.",[58,59,60],"Chronic Low Back Pain (CLBP)","Sacroiliac Joint Dysfunction","Mechanical Low Back Pain",[60,59,62,63,64],"Connective Tissue Disorders","Dry Needling","Fascia \u002F Fascial Manipulation","NOT_YET_RECRUITING","2026-01-18",{"date":68,"type":69},"2026-01-21","ACTUAL",{"date":71,"type":52},"2026-04-10",{"date":73,"type":52},"2026-09-01",{"name":5,"class":6}]